145 related articles for article (PubMed ID: 7623960)
1. Inhibition of the morphine withdrawal syndrome and the development of physical dependence by lithium in mice.
Dehpour AR; Farsam H; Azizabadi-Farahani M
Neuropharmacology; 1995 Jan; 34(1):115-21. PubMed ID: 7623960
[TBL] [Abstract][Full Text] [Related]
2. Lithium inhibits the development of physical dependence to clonidine in mice.
Dehpour AR; Sadr SS; Azizi MR; Namiranian K; Farahani M; Javidan AN
Pharmacol Toxicol; 2002 Feb; 90(2):89-93. PubMed ID: 12071431
[TBL] [Abstract][Full Text] [Related]
3. Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in mice.
Dehpour AR; Sadr SS; Nouroddini M; Shadan F; Nourozi A; Farahani M; Sahebgharani M
Hum Psychopharmacol; 2000 Mar; 15(2):87-93. PubMed ID: 12404337
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats.
You ZD; Li JH; Song CY; Lu CL; He C
Neurosci Res; 2001 Oct; 41(2):143-50. PubMed ID: 11591442
[TBL] [Abstract][Full Text] [Related]
5. Morphine and methadone dependence in the rat: withdrawal and brain met-enkephalin levels.
Pierce TL; Tiong GK; Olley JE
Pharmacol Biochem Behav; 1992 May; 42(1):91-6. PubMed ID: 1528952
[TBL] [Abstract][Full Text] [Related]
6. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
[TBL] [Abstract][Full Text] [Related]
8. Diazepam pretreatment suppresses morphine withdrawal signs in the mouse.
Suzuki T; Tsuda M; Narita M; Funada M; Mizoguchi H; Misawa M
Life Sci; 1996; 58(4):349-57. PubMed ID: 8538371
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
10. Matricaria chamomilla extract inhibits both development of morphine dependence and expression of abstinence syndrome in rats.
Gomaa A; Hashem T; Mohamed M; Ashry E
J Pharmacol Sci; 2003 May; 92(1):50-5. PubMed ID: 12832855
[TBL] [Abstract][Full Text] [Related]
11. The effect of lithium on morphine-induced analgesia in mice.
Dehpour AR; Farsam H; Azizabadi-Farahani M
Gen Pharmacol; 1994 Dec; 25(8):1635-41. PubMed ID: 7721039
[TBL] [Abstract][Full Text] [Related]
12. Naloxone precipitated morphine withdrawal and clock genes expression in striatum: A comparative study in three different protocols for the development of morphine dependence.
Roy K; Bhattacharyya P; Deb I
Neurosci Lett; 2018 Oct; 685():24-29. PubMed ID: 30030165
[TBL] [Abstract][Full Text] [Related]
13. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
14. Agmatine reduces only peripheral-related behavioral signs, not the central signs, of morphine withdrawal in nNOS deficient transgenic mice.
Aricioglu F; Paul IA; Regunathan S
Neurosci Lett; 2004 Jan; 354(2):153-7. PubMed ID: 14698461
[TBL] [Abstract][Full Text] [Related]
15. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
Bhargava HN
Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
[TBL] [Abstract][Full Text] [Related]
16. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
17. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Aug; 250(2):485-91. PubMed ID: 2760839
[TBL] [Abstract][Full Text] [Related]
18. Rapid induction of dependence to morphine in rats.
Leung CM; Dai S; Ogle CW
Neuropharmacology; 1986 Mar; 25(3):305-7. PubMed ID: 3703178
[TBL] [Abstract][Full Text] [Related]
19. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
Neal BS; Sparber SB
J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
[TBL] [Abstract][Full Text] [Related]
20. Effect of propranolol on antinociceptive and withdrawal characteristics of morphine.
Chipkin RE; Dewey WL; Harris LS; Lowenthal W
Pharmacol Biochem Behav; 1975; 3(5):843-7. PubMed ID: 1800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
